These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37930499)

  • 1. ASO Author Reflections: Tumor Necrosis-A Poor Prognostic Factor of Gallbladder Carcinoma.
    Zou RQ; Yang SQ; Dai YS; Hu HJ; Li FY
    Ann Surg Oncol; 2024 Jan; 31(1):152-153. PubMed ID: 37930499
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Preoperative Prediction Score for Early Recurrence of Resected Gallbladder Carcinoma and Consideration of Optimal Treatment Strategies.
    Shimizu Y; Ashida R; Sugiura T; Okamura Y; Ohgi K; Yamada M; Otsuka S; Aramaki T; Notsu A; Uesaka K
    Ann Surg Oncol; 2022 Sep; 29(9):5458-5459. PubMed ID: 35650368
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Contemporary Analysis of Impact of Lymphadenectomy on Survival in Nonmetastatic Gallbladder Cancer.
    Kemp Bohan PM; Nelson DW; Vreeland TJ
    Ann Surg Oncol; 2021 Jun; 28(6):2973-2974. PubMed ID: 33560490
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms.
    Zhang Q; Wang Y; Liang T
    Ann Surg Oncol; 2022 Nov; 29(12):7631. PubMed ID: 35794367
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Surgical Middle Ground-Navigating the Intraoperatively Detected Incidental Suspicious Gallbladder Wall Thickening: "The Parray's Approach".
    Parray AM
    Ann Surg Oncol; 2024 Feb; 31(2):1282-1283. PubMed ID: 38032466
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Validated Prediction Model of Early Recurrence after Resection for Gallbladder Cancer: Identifying a Subset of Patients Who May be Better Served with Neoadjuvant Therapy.
    Sahara K; Tsilimigras DI; Pawlik TM
    Ann Surg Oncol; 2021 Jan; 28(1):428-429. PubMed ID: 32880034
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Robotic Radical Surgery for Incidental Gallbladder Cancer is on the Rise.
    Machado MAC; Lobo Filho M; Makdissi F
    Ann Surg Oncol; 2023 Jun; 30(6):3398-3399. PubMed ID: 36967452
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Can Indocyanine Green Increase the Safety of Bile Duct Dissection and Thus Improve Regional Lymphadenectomy in Re-Do Surgery for Incidental Gallbladder Cancer?
    Anselmo A; Siragusa L; Materazzo M; Sforza D; Bacchiocchi G; Sensi B; Tisone G
    Ann Surg Oncol; 2022 Sep; 29(9):5554. PubMed ID: 35739363
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Gallbladder Cancer Research, "One for All and All for One" Strategy to Improve Research.
    Vega EA; Newhook TE; Vauthey JN
    Ann Surg Oncol; 2021 May; 28(5):2683-2684. PubMed ID: 33718976
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant hemangiopericytoma of the gallbladder.
    Gupta S; Padmanabhan A; Khanna S
    J Surg Oncol; 1983 Mar; 22(3):171-4. PubMed ID: 6834835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASO Author Reflections: Failing to Adhere to Treatment Guidelines in Gallbladder Cancer.
    Papageorge MV; Sachs TE
    Ann Surg Oncol; 2021 Jun; 28(6):2958-2959. PubMed ID: 33555452
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Precision in Gallbladder Cancer Care: Present Challenges and Future Directions.
    Mellado S; Chirban AM; Rivera B; Panettieri E; Vega EA
    Ann Surg Oncol; 2023 Oct; 30(11):6601-6602. PubMed ID: 37548834
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: CTCs in Patients with Gallbladder Adenocarcinoma.
    Cai W
    Ann Surg Oncol; 2023 Dec; 30(13):8009. PubMed ID: 37620537
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic Significance of Tumor Necrosis in Patients with Gallbladder Carcinoma Undergoing Curative-Intent Resection.
    Yang SQ; Wang JK; Ma WJ; Liu F; Zou RQ; Dai YS; Lv TR; Li FY; Hu HJ
    Ann Surg Oncol; 2024 Jan; 31(1):125-132. PubMed ID: 37884700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASO Author Reflections: Revision Surgery or Timely Chemotherapy for Incidental Gallbladder Cancers: What is Actually Helping?
    Patkar S; Patel S; Goel M
    Ann Surg Oncol; 2021 Oct; 28(11):6767-6768. PubMed ID: 33590364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallbladder carcinoma: analysis of prognostic factors in 132 cases.
    Wang RT; Xu XS; Liu J; Liu C
    Asian Pac J Cancer Prev; 2012; 13(6):2511-4. PubMed ID: 22938413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASO Author Reflections: Survival Benefit of Adjuvant Chemoradiotherapy for Gallbladder Cancer: The Role of Radiation Therapy Revisited.
    Kim BH; Chie EK; Kim K
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):788-789. PubMed ID: 30324480
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Gallbladder Cancer Predictive Risk Score Based on Pathological Findings: A Propensity Score-Matched Analysis.
    Abe T
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):790-791. PubMed ID: 30315386
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of prognostic factors after curative resection for gallbladder carcinoma].
    Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
    Korean J Gastroenterol; 2006 Jul; 48(1):32-6. PubMed ID: 16861879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflection: Trends and Impact of Adjuvant Chemotherapy in Resected Gallbladder Cancer: Going Beyond Trial Data.
    Bohan PMK; Nelson DW
    Ann Surg Oncol; 2021 Mar; 28(3):1481-1482. PubMed ID: 32761329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.